Journal of Asthma and Allergy
Volume 14, 2021 - Issue
Open access
127
Views
4
CrossRef citations to date
0
Altmetric
Original Research
Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
Charlene M Prazma1 Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USACorrespondence[email protected]
View further author information
, View further author information
Marco Idzko2 Division of Pneumology, Medical University of Vienna, Vienna, Austria;3 Department of Pneumology, University Hospital Freiburg, Freiburg, GermanyView further author information
, Jo Anne Douglass4 The Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, AustraliaView further author information
, Arnaud Bourdin5 Departement de Pneumologie et Addictologie, Hôpital Arnaud de Villeneuve, CHU Montpellier, Montpellier, France;6 PhyMedExp, University of Montpellier, Montpellier, France
https://orcid.org/0000-0002-4645-5209View further author information
Stephen Mallett7 Clinical Statistics, GSK, Uxbridge, Middlesex, UKView further author information
, Frank C Albers8 Respiratory Medical Franchise, GSK, Research Triangle Park, NC, USA
https://orcid.org/0000-0001-7039-4621View further author information
Steven W Yancey1 Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USAView further author information
show all
Pages 675-683
|
Published online: 14 Jun 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.